JP2016512251A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016512251A5 JP2016512251A5 JP2016500564A JP2016500564A JP2016512251A5 JP 2016512251 A5 JP2016512251 A5 JP 2016512251A5 JP 2016500564 A JP2016500564 A JP 2016500564A JP 2016500564 A JP2016500564 A JP 2016500564A JP 2016512251 A5 JP2016512251 A5 JP 2016512251A5
- Authority
- JP
- Japan
- Prior art keywords
- mutation
- cell epitope
- sarcin polypeptide
- polypeptide
- modified
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920001184 polypeptide Polymers 0.000 claims 42
- 102000004196 processed proteins & peptides Human genes 0.000 claims 42
- 108090000765 processed proteins & peptides Proteins 0.000 claims 42
- 230000035772 mutation Effects 0.000 claims 40
- 210000001744 T-lymphocyte Anatomy 0.000 claims 37
- FBUTXZSKZCQABC-UHFFFAOYSA-N 2-amino-1-methyl-7h-purine-6-thione Chemical compound S=C1N(C)C(N)=NC2=C1NC=N2 FBUTXZSKZCQABC-UHFFFAOYSA-N 0.000 claims 15
- 108010001818 alpha-sarcin Proteins 0.000 claims 15
- 150000001413 amino acids Chemical class 0.000 claims 10
- 230000014616 translation Effects 0.000 claims 6
- 102220493377 Sodium/calcium exchanger 3_N16R_mutation Human genes 0.000 claims 5
- 125000003275 alpha amino acid group Chemical group 0.000 claims 5
- 239000003937 drug carrier Substances 0.000 claims 5
- 239000000546 pharmaceutical excipient Substances 0.000 claims 5
- 102220011660 rs63751099 Human genes 0.000 claims 5
- 239000001752 chlorophylls and chlorophyllins Substances 0.000 claims 4
- 108020001507 fusion proteins Proteins 0.000 claims 4
- 102000037865 fusion proteins Human genes 0.000 claims 4
- 238000001243 protein synthesis Methods 0.000 claims 4
- 102220179712 rs369544006 Human genes 0.000 claims 4
- 102220554178 APC membrane recruitment protein 1_Q10A_mutation Human genes 0.000 claims 3
- 102220510658 APC membrane recruitment protein 1_Y18H_mutation Human genes 0.000 claims 3
- 102220626031 D-beta-hydroxybutyrate dehydrogenase, mitochondrial_T15Q_mutation Human genes 0.000 claims 3
- 102220493485 Sodium/calcium exchanger 3_N16A_mutation Human genes 0.000 claims 3
- 102200103621 rs267607030 Human genes 0.000 claims 3
- 102220098144 rs35849100 Human genes 0.000 claims 3
- 239000000427 antigen Substances 0.000 claims 2
- 102000036639 antigens Human genes 0.000 claims 2
- 108091007433 antigens Proteins 0.000 claims 2
- 238000003556 assay Methods 0.000 claims 2
- 239000012634 fragment Substances 0.000 claims 2
- 238000000338 in vitro Methods 0.000 claims 2
- 230000005764 inhibitory process Effects 0.000 claims 2
- 238000013518 transcription Methods 0.000 claims 2
- 230000035897 transcription Effects 0.000 claims 2
- 230000005867 T cell response Effects 0.000 claims 1
- 230000001413 cellular effect Effects 0.000 claims 1
- 231100000331 toxic Toxicity 0.000 claims 1
- 230000002588 toxic effect Effects 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361783589P | 2013-03-14 | 2013-03-14 | |
| US61/783,589 | 2013-03-14 | ||
| US201361902972P | 2013-11-12 | 2013-11-12 | |
| US61/902,972 | 2013-11-12 | ||
| PCT/US2014/020035 WO2014158770A1 (en) | 2013-03-14 | 2014-03-03 | Ribotoxin molecules derived from sarcin and other related fungal ribotoxins |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016512251A JP2016512251A (ja) | 2016-04-25 |
| JP2016512251A5 true JP2016512251A5 (enExample) | 2017-04-06 |
| JP6203372B2 JP6203372B2 (ja) | 2017-09-27 |
Family
ID=51625052
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016500564A Active JP6203372B2 (ja) | 2013-03-14 | 2014-03-03 | サルシン及び他の関連する真菌リボトキシンに由来するリボトキシン分子 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US9603911B2 (enExample) |
| EP (1) | EP2971038B1 (enExample) |
| JP (1) | JP6203372B2 (enExample) |
| AU (1) | AU2014241891B2 (enExample) |
| CA (1) | CA2903252C (enExample) |
| DK (1) | DK2971038T3 (enExample) |
| ES (1) | ES2765302T3 (enExample) |
| PL (1) | PL2971038T3 (enExample) |
| PT (1) | PT2971038T (enExample) |
| SI (1) | SI2971038T1 (enExample) |
| WO (1) | WO2014158770A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9603911B2 (en) * | 2013-03-14 | 2017-03-28 | Research Corporation Technologies, Inc. | Ribotoxin molecules derived from sarcin and other related fungal ribotoxins |
| WO2017053290A1 (en) * | 2015-09-23 | 2017-03-30 | Research Corporation Technologies, Inc. | Ribotoxin molecules derived from sarcin and other related fungal ribotoxins |
| WO2020118192A1 (en) * | 2018-12-07 | 2020-06-11 | Genome Protection, Inc. | Engineered flagellin-derived compositions and uses |
| WO2022038152A1 (en) * | 2020-08-17 | 2022-02-24 | Atb Therapeutics | Recombinant immunotoxin comprising a ribotoxin or rnase |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU654563B2 (en) * | 1991-07-24 | 1994-11-10 | Imperial Chemical Industries Plc | Proteins |
| US8114969B2 (en) | 2003-10-01 | 2012-02-14 | Isis Innovation, Ltd. | Immunotoxin derived from a recombinant human autoantibody and method of using thereof |
| WO2006076417A1 (en) | 2005-01-12 | 2006-07-20 | Proteonova, Inc. | Method for making targeted therapeutic agents |
| US9603911B2 (en) * | 2013-03-14 | 2017-03-28 | Research Corporation Technologies, Inc. | Ribotoxin molecules derived from sarcin and other related fungal ribotoxins |
-
2014
- 2014-03-03 US US14/774,445 patent/US9603911B2/en active Active
- 2014-03-03 JP JP2016500564A patent/JP6203372B2/ja active Active
- 2014-03-03 CA CA2903252A patent/CA2903252C/en active Active
- 2014-03-03 PL PL14775634T patent/PL2971038T3/pl unknown
- 2014-03-03 WO PCT/US2014/020035 patent/WO2014158770A1/en not_active Ceased
- 2014-03-03 SI SI201431442T patent/SI2971038T1/sl unknown
- 2014-03-03 EP EP14775634.0A patent/EP2971038B1/en active Active
- 2014-03-03 PT PT147756340T patent/PT2971038T/pt unknown
- 2014-03-03 AU AU2014241891A patent/AU2014241891B2/en not_active Ceased
- 2014-03-03 ES ES14775634T patent/ES2765302T3/es active Active
- 2014-03-03 DK DK14775634.0T patent/DK2971038T3/da active
-
2017
- 2017-02-13 US US15/430,906 patent/US9976131B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018520654A5 (enExample) | ||
| JP2005120106A5 (enExample) | ||
| JP2016104045A5 (enExample) | ||
| JP2020513804A5 (enExample) | ||
| JP2012095652A5 (enExample) | ||
| JP2014518883A5 (enExample) | ||
| FI3683235T3 (fi) | Anti-IL-33-vasta-aineita ja niiden käyttöjä | |
| JP2020501532A5 (enExample) | ||
| JP2010273685A5 (enExample) | ||
| JP2013172734A5 (enExample) | ||
| WO2019126634A3 (en) | Targeted integration of nucleic acids | |
| JP2015146822A5 (enExample) | ||
| IL288541B (en) | Vaccine against rsv | |
| JP2015212284A5 (enExample) | ||
| JP2012126742A5 (enExample) | ||
| HRP20191608T1 (hr) | Proteini s ponavljajućim dipeptidom kao terapeutsko ciljno mjesto kod neurodegenerativnih bolesti s ekspanzijom ponavljajućeg heksanukleotida | |
| JP2015096070A5 (enExample) | ||
| JP2018198596A5 (enExample) | ||
| JP2014237714A5 (enExample) | ||
| JP2019187424A5 (enExample) | ||
| JP2014506790A5 (enExample) | ||
| JP2016185981A5 (enExample) | ||
| JP2010502207A5 (enExample) | ||
| HRP20200262T1 (hr) | Protutijela protiv cd40 i njihova upotreba | |
| JP2012000112A5 (enExample) |